With one in five African children lacking access to all needed and basic life-saving vaccines, ministers of health and other line ministers countries committed themselves to keep immunization at the forefront of efforts to reduce child mortality, morbidity and disability.
Ahead of first-ever Ministerial Conference on Immunization in Africa, new report highlights progress and challenges toward providing universal access to immunization.
Global vaccine experts and officials from all 26 African “meningitis belt” countries have convened in Addis Ababa, Ethiopia to celebrate one of Africa’s biggest public health achievements—the introduction of a vaccine, MenAfriVac®, designed, developed, and produced for use in Africa, that in five years of use has nearly eliminated serogroup A meningococcal disease from meningitis belt countries and is now being integrated into routine national immunization programs.
Global vaccine experts and officials from all 26 African “meningitis belt” countries will convene in Ethiopia next week in advance of the Ministerial Conference on Immunization to celebrate one of Africa’s biggest public health achievements—the introduction of a vaccine that in five years of use has protected more than 235 million people in 16 countries, nearly eliminating meningitis A disease on the continent.
4 December 2015 – African leaders, including ministers of health, finance, and other line ministries, will gather in Addis Ababa, Ethiopia, on 24-25 February 2016, for the Ministerial Conference on Immunization in Africa – the first-ever ministerial-level convening with a singular focus on ensuring that people across the continent can get access to life-saving vaccines.